ValuentumAd

Official PayPal Seal













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Feb 21, 2016
Growing Cautious on Teva Pharma
Best Ideas Newsletter portfolio holding Teva Pharmaceuticals reported a disappointing fourth quarter.
Feb 20, 2016
Saturday Morning Musings: Nelson’s Two Pet Peeves
Netflix is yet another example of how “growth” investors fail to account for the interim period between today and what might be, a best-case scenario of “castles in the air” fraught with euphoric estimation risk.
Feb 18, 2016
5 Things New Subscribers (or Not-So-New Subscribers) Should Do
With thousands of reports, even more articles, discounted cash-flow models, newsletter portfolios and beyond, it’s easy to get lost in all the information available at Valuentum. This article points to 5 things new subscribers (or not-so-new-subscribers) should do.
Feb 18, 2016
Warming Up to IBM, Walmart Disappoints Again
A long-time Warren Buffett favorite may be bottoming, while one of the biggest discount retailers continues to disappoint.
Feb 17, 2016
Netflix Shareholders Need to Get Real?
We’re worried about the individual investor that may be focused solely on growth metrics and not intrinsic value, of which growth is a component. Once technicals break down at Netflix, fundamental investors are going to get hurt in big way.
Feb 17, 2016
Feb 16, 2016
We Like the News! Buffett Scoops Up Kinder Morgan; FVE: $20
Let’s talk about the market action February 16.
Feb 15, 2016
Alert: 5 Reasons Why We Think Netflix’s Shares Will Collapse
The content distributor’s equity is considerably vulnerable. Beware.
Feb 14, 2016
Dividend Increases/Decreases for the Week Ending February 12
Let's take a look at companies raising their dividends this week.
Feb 12, 2016
Your Hard-Earned Money
Valuentum is releasing its February Best Ideas Newsletter early, February 12, in light of Presidents’ Day weekend.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.